Cargando…
Bacteriophage Procurement for Therapeutic Purposes
Bacteriophages (phages), discovered 100 years ago, are able to infect and destroy only bacterial cells. In the current crisis of antibiotic efficacy, phage therapy is considered as a supplementary or even alternative therapeutic approach. Evolution of multidrug-resistant and pandrug-resistant bacter...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981656/ https://www.ncbi.nlm.nih.gov/pubmed/27570518 http://dx.doi.org/10.3389/fmicb.2016.01177 |
_version_ | 1782447641892749312 |
---|---|
author | Weber-Dąbrowska, Beata Jończyk-Matysiak, Ewa Żaczek, Maciej Łobocka, Małgorzata Łusiak-Szelachowska, Marzanna Górski, Andrzej |
author_facet | Weber-Dąbrowska, Beata Jończyk-Matysiak, Ewa Żaczek, Maciej Łobocka, Małgorzata Łusiak-Szelachowska, Marzanna Górski, Andrzej |
author_sort | Weber-Dąbrowska, Beata |
collection | PubMed |
description | Bacteriophages (phages), discovered 100 years ago, are able to infect and destroy only bacterial cells. In the current crisis of antibiotic efficacy, phage therapy is considered as a supplementary or even alternative therapeutic approach. Evolution of multidrug-resistant and pandrug-resistant bacterial strains poses a real threat, so it is extremely important to have the possibility to isolate new phages for therapeutic purposes. Our phage laboratory and therapy center has extensive experience with phage isolation, characterization, and therapeutic application. In this article we present current progress in bacteriophages isolation and use for therapeutic purposes, our experience in this field and its practical implications for phage therapy. We attempt to summarize the state of the art: properties of phages, the methods for their isolation, criteria of phage selection for therapeutic purposes and limitations of their use. Perspectives for the use of genetically engineered phages to specifically target bacterial virulence-associated genes are also briefly presented. |
format | Online Article Text |
id | pubmed-4981656 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-49816562016-08-26 Bacteriophage Procurement for Therapeutic Purposes Weber-Dąbrowska, Beata Jończyk-Matysiak, Ewa Żaczek, Maciej Łobocka, Małgorzata Łusiak-Szelachowska, Marzanna Górski, Andrzej Front Microbiol Microbiology Bacteriophages (phages), discovered 100 years ago, are able to infect and destroy only bacterial cells. In the current crisis of antibiotic efficacy, phage therapy is considered as a supplementary or even alternative therapeutic approach. Evolution of multidrug-resistant and pandrug-resistant bacterial strains poses a real threat, so it is extremely important to have the possibility to isolate new phages for therapeutic purposes. Our phage laboratory and therapy center has extensive experience with phage isolation, characterization, and therapeutic application. In this article we present current progress in bacteriophages isolation and use for therapeutic purposes, our experience in this field and its practical implications for phage therapy. We attempt to summarize the state of the art: properties of phages, the methods for their isolation, criteria of phage selection for therapeutic purposes and limitations of their use. Perspectives for the use of genetically engineered phages to specifically target bacterial virulence-associated genes are also briefly presented. Frontiers Media S.A. 2016-08-12 /pmc/articles/PMC4981656/ /pubmed/27570518 http://dx.doi.org/10.3389/fmicb.2016.01177 Text en Copyright © 2016 Weber-Dąbrowska, Jończyk-Matysiak, Żaczek, Łobocka, Łusiak-Szelachowska and Górski. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Weber-Dąbrowska, Beata Jończyk-Matysiak, Ewa Żaczek, Maciej Łobocka, Małgorzata Łusiak-Szelachowska, Marzanna Górski, Andrzej Bacteriophage Procurement for Therapeutic Purposes |
title | Bacteriophage Procurement for Therapeutic Purposes |
title_full | Bacteriophage Procurement for Therapeutic Purposes |
title_fullStr | Bacteriophage Procurement for Therapeutic Purposes |
title_full_unstemmed | Bacteriophage Procurement for Therapeutic Purposes |
title_short | Bacteriophage Procurement for Therapeutic Purposes |
title_sort | bacteriophage procurement for therapeutic purposes |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981656/ https://www.ncbi.nlm.nih.gov/pubmed/27570518 http://dx.doi.org/10.3389/fmicb.2016.01177 |
work_keys_str_mv | AT weberdabrowskabeata bacteriophageprocurementfortherapeuticpurposes AT jonczykmatysiakewa bacteriophageprocurementfortherapeuticpurposes AT zaczekmaciej bacteriophageprocurementfortherapeuticpurposes AT łobockamałgorzata bacteriophageprocurementfortherapeuticpurposes AT łusiakszelachowskamarzanna bacteriophageprocurementfortherapeuticpurposes AT gorskiandrzej bacteriophageprocurementfortherapeuticpurposes |